Medscape |
Fixed Chemo Combo Vyxeos Approved for High-Risk AML
Medscape A fixed combination of two chemotherapies, daunorubicin and cytarabine, in a liposome formulation, known as Vyxeos (from Jazz Pharmaceuticals), has been approved by the US Food and Drug Administration (FDA) for use in adults with two types of acute ... FDA approves first treatment for certain types of poor-prognosis acute myeloid leukemia New Treatment Approved for Acute Myeloid Leukemia FDA Approves Daunorubicin-Cytarabine Combination for AML Subtypes |
from Health - Google News http://ift.tt/2fcg03l
EmoticonEmoticon